Holen Sie sich die Stockscreener-App
2.52
0.80%
0.02
Handel nachbörslich:
2.56
0.04
+1.59%
Schlusskurs vom Vortag:
$2.50
Offen:
$2.51
24-Stunden-Volumen:
1.08M
Relative Volume:
1.04
Marktkapitalisierung:
$83.33M
Einnahmen:
$1.23M
Nettoeinkommen (Verlust:
$-28.62M
KGV:
-1.6053
EPS:
-1.5698
Netto-Cashflow:
$-14.11M
1W Leistung:
+12.00%
1M Leistung:
+35.48%
6M Leistung:
-20.50%
1J Leistung:
+27.92%
1-Tages-Spanne:
$2.41
$2.58
1-Wochen-Bereich:
$2.1795
$2.58
52-Wochen-Spanne:
$1.62
$3.84
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Firmenname
Nrx Pharmaceuticals Inc
Sektor
Branche
Telefon
484-254-6134
Adresse
1201 ORANGE STREET, WILMINGTON
Compare NRXP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.52 | 82.67M | 1.23M | -28.62M | -14.11M | -1.5698 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-02 | Eingeleitet | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications - Investing News Network
FinancialContentMilitary and First Responder Opportunity for Robotic-Enabled Transcranial Magnetic Stimulation via Neuroplastic Therapy from NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - FinancialContent
NRx Pharmaceuticals forms defense R&D subsidiary By Investing.com - Investing.com Australia
NRx Pharmaceuticals Advances Robotic TMS and Neuroplastic Therapy for Military and First Responders - citybiz
NRx Pharmaceuticals Forms Defense Subsidiary to Develop AI-Enabled Neuroplastic Therapies - citybiz
NRx says FDA finds no bioequivalence issues in ketamine filing - MSN
NRx aims robot-guided PTSD treatment at troops, first responders - Stock Titan
NRx Receives FDA Feedback on Ketamine Drug Labeling - MyChesCo
Earnings Miss: Is NRx Pharmaceuticals Inc vulnerable to short sellersTrade Performance Summary & Reliable Price Breakout Signals - baoquankhu1.vn
NRx Pharmaceuticals (NASDAQ: NRXP) Appoints First Chief Commercial Officer Ahead of Ketamine Launch - The Globe and Mail
NRx Pharmaceuticals Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer - Investing News Network
NRx Pharmaceuticals names Glenn Tyson as chief commercial officer By Investing.com - Investing.com Canada
NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer Ahead of Anticipated Drug Approvals - Quiver Quantitative
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer - Bitget
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer - GlobeNewswire Inc.
Published on: 2026-04-12 15:49:40 - baoquankhu1.vn
NRXP Forecast, Price Target & Analyst Ratings | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
Earnings Recap: Can NRx Pharmaceuticals Inc Equity Warrant outperform in the next rallyTrade Exit Report & Weekly Top Performers Watchlists - baoquankhu1.vn
NRx Pharmaceuticals Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application - marketscreener.com
NRx Pharmaceuticals, Inc. (NRXP) stock price, news, quote and history - Yahoo Finance UK
NRx Pharmaceuticals, Inc. (NRXPW) Stock Price, News, Quote & History - Yahoo! Finance Canada
NRx Pharmaceuticals Receives FDA Feedback on Preservative-Free Ketamine Label - National Today
NRx Pharmaceuticals Aligns FDA Labeling for Preservative-Free Ketamine Application - citybiz
NRx receives preliminary FDA alignment on ketamine labeling By Investing.com - Investing.com Canada
NRx Pharmaceuticals Receives Preliminary Labeling Alignment from FDA for Preservative-Free Ketamine Product - Quiver Quantitative
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application - The Manila Times
FDA flags only minor label edits for U.S.-made ketamine amid backorders - Stock Titan
NRx Pharmaceuticals (NASDAQ: NRXP) Receives FDA Labeling Feedback for Preservative-Free Ketamine Application - The Globe and Mail
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application - Bitget
H.C. Wainwright raises NRx Pharmaceuticals stock price target to $45 - Investing.com
NRx Pharmaceuticals, Inc. (NRXPW) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
NRXP Stock Price, Quote & Chart | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network - MSN
NRX Pharmaceuticals (HAM:B1Q) PB Ratio : (As of Mar. 31, 2026) - GuruFocus
NRx Pharmaceuticals, Inc. (NRXPW) stock price, news, quote and history - Yahoo Finance Singapore
Hedge Fund Bets: Is NRx Pharmaceuticals Inc backed by strong institutional buyingEarnings Overview Report & Smart Money Movement Tracker - baoquankhu1.vn
AI-Powered 'Depression Thermometer' to Aid Interventional Psychiatry Network - National Today
AI-Powered “Depression Thermometer” to Aid Interventional Psychiatry Network via Strategic Partnership with Emobot for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered "Depression Thermometer" Across its Interventional Psychiatry Network - Bitget
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary, Announces Strategic Partnership with Emobot - citybiz
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered 'Depression Thermometer” Across its Interventional Psychiatry Network - The Manila Times
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network - ChartMill
A phone app aims to catch depression relapse between clinic visits - Stock Titan
NRx says FDA will review NRX-100 without new trials - MSN
NRx Pharmaceuticals (NASDAQ:NRXP) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Has Found A Path To Profitability - simplywall.st
Nrx Pharmaceuticals’ Earnings Call Signals High‑Stakes Progress - The Globe and Mail
Published on: 2026-03-29 11:07:47 - baoquankhu1.vn
NRX Pharmaceuticals (HAM:B1Q) Cyclically Adjusted PS Ratio : (As of Apr. 01, 2026) - GuruFocus
Can NRx Pharmaceuticals Inc scale operations efficiently2026 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
NRX Pharmaceuticals (HAM:B1Q) PB Ratio : (As of Mar. 28, 2026) - GuruFocus
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):